Interrogating the molecular underpinnings of metastatic colonization
$2,713,636ZIAFY2025CANIH
Division Of Basic Sciences - Nci
Investigators
Linked publications & trials
Paper 38451783Paper 38428410Paper 38418824Paper 38280378Paper 37903316Paper 37453816Paper 37296836Paper 37170037Paper 37162991Paper 36754451Paper 36694330Paper 36581719Paper 36474095Paper 36434483Paper 36427115Paper 36400894Paper 36400892Paper 36396869Paper 36348206Paper 36316505Paper 36305989Paper 36181515Paper 35817563Paper 34216724Paper 32399263
Abstract
Our work to date has revealed an intricate role for components of the innate immune system in controlling metastatic colonization. This work has been substantiated using two ex vivo human tumor systems that keep tumor and surrounding normal tissue viable outside of the patient. The work has identified new targets in cholangiocarcinoma that has resulted in a Phase II clinical trial with multiple clinical responses. The work has also resulted in combining antibody drug conjugates with regional therapy that has resulted in improved outcomes and has, for the first time in 50 years, resulted in a potentially new drug to regional therapy pumps.
View original record on NIH RePORTER →